Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
D000109:Acetylcholine; D000731:Androstanes / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D000818:Animals; D002415:Cats; D006168:Guinea Pigs; D007928:Lethal Dose 50; D008961:Models, Structural; D008968:Molecular Conformation; D009119:Muscle Contraction / Q000187:drug effects; D009467:Neuromuscular Depolarizing Agents / Q000138:chemical synthesis*; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D010197:Pancuronium / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D000644:Quaternary Ammonium Compounds / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D012584:Sciatic Nerve / Q000187:drug effects; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects
D000731:Androstanes; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D000644:Quaternary Ammonium Compounds; D010197:Pancuronium; D000109:Acetylcholine